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To those who would relegate the permanent artificialheart to medical
history, we offer Robertlarvik. He did it once, andhe'lldo it again .

., ., .,

n Y
NAN UNASSUMING OFFICE

on the 39th floor of a high[ ] ] rise in New York City, overlooking midtown Manhattan and the Hudson River,
Dr. Robert Jarvik sits at his
Silicon Graphic IRIS super work station
refining the design of his latest artificial heart.
In front of him, on the computer screen, the
new heart rotates in three dimensions. On the
walls behind him hang framed newspaper
and magazine clippings documenting the exploits of the Jarvik-7. On a counter to the side
sit several old Jarvik hearts, including part of
the pyrolitic carbon and titanium device that
kept Barney Clark alive for 112 days.
It's been slightly more than six years since
Clark- the recipient of the first permanent
artificial heart- died on March 23, 1983. Six
years since the nation and the world held its
breath for the promise of new life.
It's bee n almost three years since the
death of Bill Schroeder, the second permanent heart recipient, who lived for a record
620 days with the Jarvik-7. T he three other
recipients of the permanent Jarvik-7, Murray
Haydon, Jack Burcham, and Leif Stenberg,
died in the interim.
In the early days, when Clark was still a
hero and families sat down to watch the news
each night to check his progress, the artificial
heart was referred to as a 'medical milestone'.
But after recurring renal failure, after complications in Clark's lungs, kidneys, and intestines, after Schroeder suffered numerous
debilitating strokes, after Burcham died only
10 days after his implant, the euphoria began
to wane.
In its place rose cries of ethical concern.
Disturbing questions were raised-regarding
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quality of life, the medical team's ability to
profit financially from the heart, the patient
selection process, and the hospital's consent
form.
The emphasis of the Jarvik-7 shifted from
its use as a permanent device to that of a
bridge to transplantation- that is, to prolong
the lives of people whose death is imminent
until a suitable human heart can be found.
Approximately 140 such surgeries have
occurred; more than half of those patients
have been totally rehabilitated. Although it's
still considered experimental surgery, many
say the device has performed flawlessly when
used as a bridge.
Fewer and fewer people view the permanent artificial heart as a viable solution for the
near or distant future. In May 1988, the National Heart, Lung and Blood Institute,
which has monitored federally funded artificial heart research since 1964, terminated
government support of total artificial heart research. T he Institute's director, Claude Lenfant, argued that the human body couldn't
seem to tolerate the artificial heart. Instead,
research would concentrate on partial ventricle assist devices that were nearly ready for
clinical testing in humans.
A New York Times editorial applauded the
decision, calling th e permanent artificial
heart "the Dracula of medical technology."
Wrote the paper: "At long last, the institute
has found the resolve to drive a stake through
its voracious creation." Despite that criticism,
some government funding for permane nt
artificial heart research remains, thanks to the
efforts of a band of influential senators who
successfully lobbied for reinstatement of an
artificial heart program.
But while some funding has been renewed, ethical dissonance regarding a permane nt artificial heart remains in both
medical circles and the public. Some believe
that human heart transplantation is the only
practical solution to advanced heart disease.
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Not Robert Jarvik. His belief in the promise of a permanent artificial heart is stronger
than ever.
Jarvik holds none of the four government
contracts funding permanent artificial heart
research. He supports his research independently, with his own money and with funding
from the private sector. Away from a major
medical center, away from federal constraints
on his creativity, energized by the pulse of the
city below him, Jarvik perfects his heart. He
believes a successful permanent artificial
heart could save 500,000 lives over 10 years.
And he believes his revolutionary new device
is the one that will do it.

[I]

HE SIZE OF AN EGG. THAT'S HOW

Jarvik describes his revolutionary
new Jarvik 2000 heart. A futuristic
name for a futuristic product.
The Jarvik 2000, which is trademarked,
uses what's known as the intraventricular approach, "a completely new concept," says
Jarvik. Instead of replacing the human heart,
instead of actually cutting it out and replacing
it with something else, the Jarvik 2000 is
placed inside the left ventricle of the natural
heart. In a case where both sides of the heart
would need to be supported, two devices
would be implanted. Nearly 70 percent of
patients will need only one. Jarvik believes
the "heart within a heart" will eliminate the
threat of infection that plagued the Jarvik-7.
The beauty of the new heart is its simplicity. It uses a hydrody namic axial fl ow
pump--similar to turbine blading on a jet engine or a ship propeller-allowing the whole
system to function with a single moving part.
It requires no heart valves and is expected to
be practically silent when implanted.
The Jarvik 2000 will be powered by an
implanted electric motor, within the chamber
of the heart, that drives the rotor magnetically. The patient will wear a battery vest connected to the heart at a socket in the patient's
J UNE
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chest. A battery weighing just a few pounds
would last six to eight hours. A cable and a
wall plug could be used while sleeping. The
patient would have full mobility and a high
quality of life. "In terms of simplicity, miniaturization, and long-term reliability, it has a
great deal of potential," says] arvik.
Right now the heart lives only in Jarvik's
computer, but he hopes to have working
models by the end of the summer. The
project will then require three to four years of
animal studies before human implants could
begin, with several more years of testing on
humans before the device could be more
widely available. Several pneumatic centers
have expressed interest in housing the
project once it proceeds. For now, it rests with
Jarvik.
"It's not sufficient to just be an inventor or
a designer or a physician these days," he says.
"You have to think about integrating the
whole thing and you have to take into account the issues such as the environment in
terms of the public attitude toward new technology and health." To meet this challenge,
Jarvik draws on his experience as a pioneer in
artificial heart research-most importantly,
the lessons learned from the ]arvik-7.

[I]

ARVIK BEGAN WORKING ON THE

artificial heart as a $100-a-week
lab assistant to Dr. William Kolff,
head of the artificial organs
department at the University of Utah and the
inventor of the first successful kidney dialysis
machine.
Although he's commonly referred to as
the "inventor" of the artificial heart, Jarvik actually adapted existing technology, revolutionizing ir in the process. "I took what was a
general concept into the realm of being able
to be used clinically," he says.
The premise of the artificial heart has circulated through medical circles for more than
150 years, bur did nor materialize until the
early fifties when a mechanical heart developed by F. D. Dodrill of General Motors was
used to bypass the heart of a patient for 50
minutes during surgery.
Kolff started experimenting with a total
artificial heart in 1957. Early models were implanted in Jogs and calves with limited success. In 1969, Dr. Denton Cooley of the
1exas Heart Institute implanted an artificial
heart in a man to keep him alive until a
suitable heart could be found for transplant.
He lived for 60 hours with rhe heart before
his transplant, but died of complications only
32 hours later.
Three years later an artificial heart designed by Clifford Kwann-Gett, a member of
Kolffs artificial organs ream, eliminated ear-
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lier problems involving mechanical dysfunction. Survival times for experimental animals
increased, but the devices continued to malfunction after about two weeks of use.
Then came Jarvik. His first heart, the Jarvik-3, replaced rhe mbber constmcrion of old
hearts with multiple layers of a smooth elastic
material similar to the lycra used in girdles.
The heart was better adapted to fit the
anatomy of lab animals, who lived up to four
months with the device.
In 1976, researchers implanted a Jarvik-5
into a calf named Abe be, who lived for an unprecedented six months. Later a calf named
Alfred Lord Tennyson was kept alive for nine
months with the heart.
With a view toward imminent human
usage, Jarvik developed a new heart that was
smaller than the others, one that would fir in-

side an average human chest. Like irs
predecessors, it would replace the two lower
ventricles of the human heart (the pans that
pump blood to the rest of the body) and
would be attached to the natural atria (the
upper chambers) of the human heart. It
would be powered pneumatically- by compressed air-from an electrical unit connected to the patient's body by tubes. It was
called the Jarvik-7.
Concerned that funding for the artificial
organs program made available by the National Institutes of Health (NIH) might
someday be cut off, Kolff formed a satellite
laboratory of rhe university- a spin-off business venture called Kolff Associates, and later
Kolff Medical-with Jarvik as his principal
associate. As Kolff was petitioning the Food
and Drug Administration (FDA) for permis-
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sion to implant the Jarvik-7 in a human,
Jarvik took the helm of the company as president and chief executive officer.
Although the FDA granted Kolff's request in September 1981, it was more than a
year before a subject was found that met the
stringent FDA and University of Utah
requirements.
On December 2, 1982, a retired dentist
suffering from cardiomyopathy-degenerative and irreversible heart disease-made
history by receiving the first permanent artificial heart. Dr. William DeVries of the University of Utah performed the seven-and-a-halfhour surgery; Jarvik assisted. With Ravel's
Bolero playing in the background, Barney
Clark was given a second chance at life.
Within four years, four more permanent
implants would occur and all five men would
die. Numerous side effects and complications arose: kidney failure, pneumonia, diarrhea, blood clots that caused strokes, and
limited mobility due to the bulky pneumatic
system. With each patient, however, the
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. ~knew
that my father
was going to die of
heart disease, and
I was trying to make
a heartfor him, "
Jarvik has said.
"/was too late. "

•••
cause of death was infection at the site of the
prosthetic device-stemming from the drive
lines that connected the heart to the power
source. The pericardia! membrane surround-

The Jarvik 2000 artificial heart will not replace the
human heart, but will fit inside the cavity of
the left ventricle. The egg-sized device will
assume the function of the ventricle,
pumping oxygenated blood through
the aorta back into the body. It is
operated by a single moving part,
powered magnetically by an electric
motor in the heart's chamber,
which is connected through
the chest to a portable
battery vest.
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ing the artificial heart had an inadequate
blood supply to fight against infection.
Jarvik says that while the Jarvik-7
demonstrated the possibility of long-term
survival with the artificial heart, his belief that
the compressed-air prosthesis was advanced
enough to be used on a widespread permanent basis was "probably the biggest mistake I have ever made . . . . I think it's
appropriate to recognize the Jarvik-7 heart as
a device of limited clinical applicability now,
but a good research device," he says.
Undeterred from his mission, Jarvik set his
sights on redeveloping the artificial heart and on
running KolffMedical. Taking the firm public,
he raised millions from investors. Kolff resigned
as chairman in 1984 and the company changed
it's name to Symbion Inc. (a combination of
symbiosis and bionic). In 1986 Symbion was
listed in Inc. magazine among the fastest-growing small companies in America.
And then another blow. In 1987, the E.M.
Warburg Pincus Co., a New York-based venture capital firm and a major investor in Kolff
Medical, instigated a successful stock takeover of Symbion. Jarvik was ousted. Everything he'd worked for was crumbling at once.

[§]

EVEN YEARS BEFORE BARNEY

Clark received his Jarvik-7, Rob
Jarvik's father, a physician, died
after open heart surgery.
"I knew that my father was going to die of
heart disease, and I was trying to make a heart
for him," Jarvik has said. "I was too late."
Growing up in Stamford, Connecticut,
Jarvik was "a kid who was always mentally
disassembling things and putting them back
together," he says. He enjoyed dabbling in
the sciences, and according to the reminiscences of a boyhood friend, used to perform
autopsies on dead animals found on the side
of the road.
During high school Jarvik worked as an
orderly at Stamford Hospital, where his father
performed general surgery. He often observed surgery at his father's side, and one
day, after watching a nurse struggle with a suture, invented a gun-like device that automatically staples-off blood vessels. The
Jarvik Suture Machine, as he called it, was the
first of his five patents (he has five more
pending on artificial heart and artificial hearing devices).
He enrolled in Syracuse University as an
architecture major, but switched to pre-med
after his father suffered an aortic aneurysm.
Jarvik says he was not "a conventional
thinker," and did not put his major effort into
his studies, a view corroborated by SU
chemistry professor Roger C. Hahn. "He always went on flights of fantasy," says Hahn.
JUNE
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The result was a 2.8 grade point average
that managed to keep him out of more than
15 medical schools. Mter graduating with a
degree in zoology in 1968, Jarvik married his
college sweetheart, Elaine Levin, a 1967 SU
grad, and packed off for Italy, where he enrolled at the University of Bologna medical
school. Classes were canceled frequently due
to student strikes and he spent much of his
time pondering theories of the universe.
After two years the couple returned to New
York where Jarvik earned a master's degree in
occupational biomechanics from New York
University.
Still determined to earn an M.D., Jarvik
moved to Salt Lake City to work for Kolff,
and with his mentor's recommendation was
admitted to the University of Utah College of
Medicine the following year. He had taken a
model of his hean with him to his entrance
interview. "I come to you with my hean in my
hands," he told the administrators.
Mter graduating in 1976, Jarvik eschewed
an internship and a residency in favor of
working full-time on the artificial heart with
Kolff. He served as assistant director of the
experimental laboratories of the university's
division of artificial organs, and as an assistant
research professor in surgery and bioengineering.
These were roller coaster years for Jarvik.
With the implant of the Jarvik-7, he was
transformed from an anonymous researcher
to a household name. During the early 80s he
was named inventor of the year by the National Inventors Hall of Fame, received an
honorary doctor of science degree from Syracuse University, was chosen by Esquire magazine as one of the outstanding Americans
under 40, received a Gentleman's Quarterly
Manstyle Award, and appeared as one of the
men beneath the eye patch in the Hathaway
shirt ads.
Despite the fame and glory, he was under
tremendous strain, pulled between commitments to Symbion, his patients, his family,
and promotion of the artificial heart. "I was
emotionally involved in th e lives of the
patients, and I was also traveling all over to
promote the program,'' Jarvikhas said. "Even
though I had a general purpose, I felt quite
scattered." His marriage ended in 1985. His
tenure as a corporate executive e nded two
years later.
With nothing to do but start over, Jarvik
began a new life. He moved to New York
City, remarried (see relatedstory), and founded
Jarvik Research to continue his work on the
artificial heart, a mission that pervades all
aspects of his life.
It's no longer a business to Jarvik, but a
long-term scientific research project. And
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graduating in 1976,
Jarvik eschewed an
internship and a
residency in favor of
workingfu/1-time on
the artificial heart.

•••
foremost in his mind are the names Clark,
Schroeder, Haydon, Burcham, and Stenberg.
"These were people who I view as having
had their lives prolonged," says Jarvik. " ...
They [each]lived an average of nine months
when their life expectancy was probably no
more than a week or maybe days in some of
the cases. .. I don't think that kind of thing
makes a person in medicine want to stop. It
just makes you all the more interested in
working it through so it can be better."
N 1985, IN AN ATIEMIT TO REGU-

late the artificial heart research
that was already in full swing, the
FDA established guidelines addressing the controversial issue of human experimentation. The New York Times wrote
that the guidelines were "framed to yield the
most knowledge at the least risk and pain to
patients," an issue that looms over Jarvik as
he develops the Jarvik 2000.
"It's a question of addressing the specific
things that we learned in the long-term use of
the Jarvik-7," says Jarvik, "making approaches to the major problems."
Those issues, of course, involve quality of
life, mobility, and freedom of complications
related to the heart. The 2000, Jarvik says,
has been the first opponunity to take all the
information learned from the Jarvik-7 and
think creatively about how to solve those
problems, which he now believes he's done.
But there are other issues, involving the
allocation of medical funds for research that
may not effect a wide segment of the population. One NIH ethicist questions the use of
scarce resources on treatment for a disease
that overwhelmingly affi icts "upper-middleclass white males," rather than on something
like prenatal care. "It's a question of getting
the most that we can for what we pay," he
says.
It should be noted, however, that heart
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disease is the nation's leading cause of death,
causing nearly 800,000 deaths at a cost of$83
billion annually. Every year, nearly 30,000
lives could be saved by heart transplant, with
only 1,500-some donor heans available.
Often it comes down to money. Opponents of the artificial hean frequently cite the
$240 million drained out of the NIH in the
last 24 years for artificial heart research. But
less than $10 million of those funds were
used on development of the Jarvik-7, the
majority supponing hean-assist devices, bioinstrumentation, and biomaterials. No fed eral monies have assisted any of the Jarvik-7
patients, permanent or bridge.
Jarvik isn't worried about money. His
research has never been funded in great part
by government support and he doesn't see
that changing in the near future.
"I don't think any of the governmentfunded systems have the potential to be practical," says Jarvik. "The problem with the
NIH programs is that they have pretty much
dictated the things that people had to do in
order to get funding.. .. Some of the more
creative and better ideas could not even be
submitted under the contract programs."
And Jarvik sees the 2000 as being a veritable medical bargain. "I think that the Jarvik
2000 is going to be durable for more than 10
years," he says. "The cost of it is going to be
lower than heart transplant when you carry it
over long term, particularly since it's not
going to require $6,000 to $8,000 a year of
drugs for follow-up .. .. I think it will be less
than dialysis. Nursing home care can cost
$40,000 a year. For roughly half that amount I
think we'll be able to rehabilitate people to have
a fully mobile lifestyle at home and back to
work."
Jarvik says there is a "zero chance" that
the anificial heart will ever be a significant
health care cost to the country. "It never is
going to be a billion dollar item or more unless it's extremely successful," he says. "And
if it's so successful that it can be applied that
widely then it will be very valuable. There is
not much risk in my mind that it becomes a
thing in which a large amount of cost is expended for very little value."
He believes the Jarvik 2000 has an excellent chance of becoming equivalent to heart
transplants in terms of cost and patient quality of life. If so, he will be several steps closer
to a goal he set for himself nearly two decades
ago when he began his artificial heart research. As he wrote in 1981, in an article titled
"The Artificial Heart" for Scientific American:
"If the anificial heart is ever to achieve its objective, it must be more than a pump. It must
also be more than functional, reliable, and
dependable. It must be forgettable."
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So WHo BALANCES THE CHEClfffiOOK?

[I]

hey've been dubbed "the
smartest couple in the
world," and "atrue meeting
of the minds." Whatever the
label, the marriage of artificial heart
pioneer Dr. Robert Jarvik and Marilyn vas
Savant, who has the highest intelligence
ever measured, is undoubtedly a cerebral
love affair.
The couple met in 1986 in what became a highly reported courtship. Jarvik
was captivated by vas Savant, apparently
after reading amedia story about her
228 10 (88 points higher than ordinary
genius). He got vas Savant's unlisted
phone number from mutual acquaintances and left a message with her
secretary that he was interested in
meeting her.
Vas Savant was less than thrilled,
imagining him to be adull, research type.
But after seeing a bare-chested photo of
the athletic physician in Vanity Fair, her
interest was piqued .. She returned his call.
The couple began to speak for hours a
day on the telephone. Amonth after the
first conversation they had a "date:" a
weekend together in Los Angeles (he was
living in Salt Lake City, she in New York).
Jarvik proposed five days after meeting
vas Savant in person. They were married a
year later in aceremony at the Plaza Hotel.
Jarvik made their wedding rings out of
gold-trimmed pyrolitic carbon-a permanent substance he used for the valves
of the Jarvik-7. 1saac Asimov escorted the
bride down the aisle. Tom Gaidosh, who
Iived with aJarvik-7 for four days in 1985
before receiving a heart transplant, was
best man.
Two years later, they are still clearly
enamored of each other and spend nearly
all their timetogether. Vas Savant, who
retains her mother's maiden name,
describes her husband as "a hero" and
"absolutely the most brilliant person I've
ever met."
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Jarvik, who believed he would never
remarry, credits his wife with dramatically
changing his life. "I've learned a great
deal from her," he says. She has taught
him to have more patience with his heart
research. "To sum it up, I've matured a
great deal since I've known her," he says.
They live and work together in New
York City ("the intellectual capital of the
world," says Jarvik), their joint offices
across the hall from their apartment.
The Jarviks travel nearly 50 percent of
the year: Paris, Rome, Caracas, and almost anywhere in the United States. When
at home, they live by routine. Up at dawn
for a quick cup of coffee before venturing
across the hall to work. They spend the
morning at their computers: Jarvik working with computer-aided design (which
vas Savant is learning to use), vas Savant
at her IBM PC, where she works on her
column for Parade magazine or on her
book- afuturistic political thriller.
By afternoon, they're generally working
together, responding to mail and telephone calls and doing some collaborative
thinking. "''ll come up with some almost

off-the-wall suggestions for the heart,"
says vas Savant, "because I can't tell ,
frankly, what is off the wall. He can tel l. I
tell him these things and sometimes they
set him thinking."
Jarvik uses his wife to keep his enthusiasm in check. "She is very interested in
what constitutes actual reality rather than
wishful thinking," he says.
They eat dinner out nearly every night
(vas Savant does not cook, "for humanitarian reasons," she says), generally walking
to ethnic restaurants in the neighborhood.
On the rare occasion that they dine at
home. it's Jarvik who prepares the meal.
After dinner it's back to the office,
wherethey work uninterrupted until one
o'clock or so. Jarvik believes it's afallacy
to distinguish between work and leisure. "I
don't have any spare time," he says.
"I spend time with life. I think there's such
athorough interaction between what constitutes work and what constitutes personallife, liie of the mind, etc., that it all
comes together." And it always involves
matters of the heart.
-R.G.L.
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